MedPath

The effect of methylprednisolone on the neuromuscular blockade reversal effect of sugammadex

Not Applicable
Recruiting
Conditions
Not Applicable
Registration Number
KCT0002239
Lead Sponsor
Bundang CHA General Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
30
Inclusion Criteria

Patients undergoing transsphenodial approach surgery for pituitary tumor
American Society of Anesthesiologists (ASA) physical status classification system of I-II
Aged 20-60 years

Exclusion Criteria

Difficult intuvbation was anticipated
If patients had a neuromuscular disorder that could impair neuromuscular block
Significant renal or hepatic dysfunction
A (family) history of malignant hyperthermia
Allergy to narcotics, neuromuscular blocking agents, or other medication used during general anesthesia
Receiving medications expected to interfere with the neuromuscular blocking agents

Study & Design

Study Type
Interventional Study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The time from the start of sugammadex administration until recovery ot the TOF ratio to 0.9
Secondary Outcome Measures
NameTimeMethod
Oxygen saturation;Respiratory rate;Blood pressure
© Copyright 2025. All Rights Reserved by MedPath